13-2-1　ⓔ文献

  1. Smolen JS, Aletaha D, et al: Rheumatoid arthritis. Nat Rev Dis Primers, 2018; 8: 18001.

  2. McInnes IB, Schett G: Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet, 2017; 389: 2328–2337

  3. Aletaha D, Neogi T, et al: 2010 Rheumatoid arthritis classification criteria. Arthritis Rheum, 2010; 62: 2569–2581.

  4. Felson DT, Smolen JS, et al: American college of rheumatology/European league against rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis, 2011; 70: 404–413.

  5. Smolen JS, Landewé RBM, et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease–modifying antirheumatic drugs: 2019 update. Ann Rheum Dis, 2020; 79: 685–699.